Skip to content
SecularTimes
  • HOME
  • WORLD
  • POLITICS
  • ENTERTAINMENT
  • AUTOMOBILE
  • BUSINESS
  • TECHNOLOGY
  • LIFESTYLE
  • HEALTH
  • MORE
    • COVID-19
    • COMICS
    • SPORTS
    • SCIENCE
    • TRAVEL

Novartis AG

Wall Street mulls over Amgen weight loss drug data

by Sven Aggesen
Wall Street mulls over Amgen weight loss drug data

The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images A version of this article first appeared in CNBC’s …

Read more

Eli Lilly’s cholesterol pill impresses in trial

by Sven Aggesen
Eli Lilly’s cholesterol pill impresses in trial

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. A sign …

Read more

Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says

by Sven Aggesen
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says

The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to enter into the “frenzy” of weight loss drugs, preferring instead to focus on areas where …

Read more

Medicare releases prices for first 10 drugs subject to negotiations

by Tudur Aled
Medicare releases prices for first 10 drugs subject to negotiations

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | …

Read more

Drugmakers on new negotiated prices with Medicare

by Sven Aggesen
Drugmakers on new negotiated prices with Medicare

President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023. Chris Kleponis | Bloomberg | Getty Images Think a friend or …

Read more

First Medicare drug price negotiations round nears end

by Sven Aggesen
First Medicare drug price negotiations round nears end

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | …

Read more

This up-and-coming cancer treatment could be a $25 billion market opportunity

by Sven Aggesen
This up-and-coming cancer treatment could be a  billion market opportunity

Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall Street are calling a “massive opportunity.” It’s called …

Read more

Google’s Demis Hassabis tasked with turning AI research into profits

by Joseph Addison
Google’s Demis Hassabis tasked with turning AI research into profits

Demis Hassabis is a celebrated name in artificial intelligence research. He’s a chess master and a neuroscientist. On Wall Street, he’s less known. That may not be true for long. …

Read more

FTC challenges patents held by drugmakers, including for Ozempic

by Tudur Aled
FTC challenges patents held by drugmakers, including for Ozempic

A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023.  Lee Smith | Reuters The Federal Trade Commission on Tuesday said it …

Read more

GRANOLAS stocks power Europe to record highs, drawing Magnificent 7 comparisons

by Sven Aggesen
GRANOLAS stocks power Europe to record highs, drawing Magnificent 7 comparisons

The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024.  Staff | Reuters Over the last 12 months, just 11 stocks …

Read more

Older posts
Page1 Page2 Page3 Next →

Recent Posts

  • The Role of Technology in Driving Innovation and Growth in UK Businesses
  • Steven Bartlett accused of amplifying dangerous health claims on his podcast | Podcasting
  • 2025 Volkswagen Taos Is Exactly What You Think It’s Going To Be
  • Canadians concerned country’s children are too soft, with no coping skills: survey
  • Apple MacBook Pro 16-inch (M4 Pro and M4 Max) review: still on top

Recent Comments

No comments to show.
  • ABOUT US
  • CONTACT US
  • PRIVACY POLICY
  • COOKIES POLICY
  • DISCLAIMER
  • TERMS OF USE
  • DMCA
© 2025 SecularTimes • Built with GeneratePress